Pneumagen


Pneumagen develops glycan targeted carbohydrate binding modules (CBMs) for respiratory tract infections ) and cancer.


Org chart

Douglas Thomson
Chief Executive Officer
Collapse
David Brady
Head of BD
Mingkui Zhou
Head Of Research

Board & advisors

Thomas Engelen
Non-Executive Chairman
Garry Taylor
Director & Chairman
Mark R. Bamforth
Non-Executive Director
Jürgen Haas
Scientific Advisory Board Member
John Skehel
Scientific Advisory Board Member
Richard Webby
Scientific Advisory Board Member
Moira Whyte
Scientific Advisory Board Member


Offices